Castle Biosciences, Inc. (CSTL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.76
Day's range
$27.03

Castle Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 05/13/2026 2.98 M $73.23 M   -3.94% 10.17%
RTW INVESTMENTS, LP 05/15/2026 2.76 M $67.72 M   30.40% 9.40%
PRINCIPAL FINANCIAL GROUP INC 05/04/2026 1.77 M $43.45 M   -2.09% 6.03%
PORTOLAN CAPITAL MANAGEMENT, LLC 05/15/2026 1.35 M $33.15 M   -21.92% 4.60%
05/15/2026 1.18 M $28.91 M   100.00% 4.01%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 1.04 M $25.52 M   -9.10% 3.54%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 05/15/2026 940.69 K $23.09 M   -11.15% 3.21%
05/08/2026 861.77 K $21.16 M   100.00% 2.94%
ALLIANZ ASSET MANAGEMENT GMBH 05/11/2026 811.32 K $19.92 M   30.38% 2.77%
STATE STREET CORP 05/15/2026 769.08 K $18.88 M   4.43% 2.62%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 728.10 K $17.88 M   1.84% 2.48%
AIGH CAPITAL MANAGEMENT LLC 04/30/2026 590.60 K $14.50 M   -5.46% 2.01%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 559.58 K $13.74 M   137.60% 1.91%
PALISADE CAPITAL MANAGEMENT, LP 05/15/2026 535.88 K $13.16 M   -5.62% 1.83%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 532.80 K $13.08 M   8.05% 1.82%
NUVEEN, LLC 04/30/2026 522.13 K $12.82 M   -0.49% 1.78%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 484.44 K $11.88 M   24.09% 1.65%
WASATCH ADVISORS LP 04/21/2026 455.04 K $11.17 M   -15.30% 1.55%
MORGAN STANLEY 05/15/2026 428.93 K $10.53 M   110.70% 1.46%
EVENTIDE ASSET MANAGEMENT, LLC 05/15/2026 386.43 K $9.49 M   26.70% 1.32%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 377.08 K $9.26 M   -2.94% 1.29%
MILLENNIUM MANAGEMENT LLC 05/15/2026 353.32 K $8.67 M   14.37% 1.20%
GOLDMAN SACHS GROUP INC 05/15/2026 341.17 K $8.38 M   18.78% 1.16%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/14/2026 298.94 K $7.04 M   -39.26% 1.02%
NORTHERN TRUST CORP 05/14/2026 273.10 K $6.70 M   4.14% 0.93%
SILVERCREST ASSET MANAGEMENT GROUP LLC 05/15/2026 268.54 K $6.59 M   30.99% 0.92%
KORNITZER CAPITAL MANAGEMENT INC /KS 04/30/2026 264.40 K $6.49 M   -1.25% 0.90%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 255.18 K $6.26 M   3.35% 0.87%
TWO SIGMA INVESTMENTS, LP 05/15/2026 248.84 K $6.11 M   196.01% 0.85%
ADVISORS CAPITAL MANAGEMENT, LLC 05/01/2026 248.38 K $6.10 M   -0.92% 0.85%
SG AMERICAS SECURITIES, LLC 04/16/2026 244.89 K $6.01 M   1,051.75% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 241.88 K $5.94 M   -0.27% 0.82%
NEW YORK STATE COMMON RETIREMENT FUND 05/06/2026 233.05 K $5.72 M   0.00% 0.79%
TUDOR INVESTMENT CORP ET AL 05/15/2026 222.98 K $5.47 M   33.38% 0.76%
PANAGORA ASSET MANAGEMENT INC 05/14/2026 222.35 K $5.46 M   383.43% 0.76%
D. E. SHAW & CO., INC. 05/15/2026 211.97 K $5.20 M   32.72% 0.72%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 188.21 K $4.62 M   100.00% 0.64%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 05/05/2026 160.66 K $3.94 M   0.94% 0.55%
CAMPBELL & CO INVESTMENT ADVISER LLC 05/15/2026 148.82 K $3.65 M   100.00% 0.51%
EMPOWERED FUNDS, LLC 06/16/2026 132.18 K $3.25 M   8.42% 0.45%
TREXQUANT INVESTMENT LP 05/15/2026 130.43 K $3.20 M   101.89% 0.44%
PARKMAN HEALTHCARE PARTNERS LLC 05/15/2026 126.15 K $3.10 M   -16.21% 0.43%
BNP PARIBAS ARBITRAGE, SNC 05/12/2026 122.16 K $3.00 M   -18.57% 0.42%
CITADEL ADVISORS LLC 05/15/2026 120.98 K $2.97 M   -66.98% 0.41%
FRANKLIN RESOURCES INC 05/13/2026 90.91 K $2.23 M   12.79% 0.31%
JPMORGAN CHASE & CO 05/13/2026 88.77 K $2.09 M   -1.40% 0.30%
BANK OF NEW YORK MELLON CORP 05/05/2026 88.65 K $2.18 M   1.92% 0.30%
AMERICAN CENTURY COMPANIES INC 05/15/2026 79.11 K $1.94 M   1.72% 0.27%
BRINKER CAPITAL INVESTMENTS, LLC 05/13/2026 74.90 K $1.84 M   0.33% 0.26%
MACKENZIE FINANCIAL CORP 05/13/2026 74.11 K $1.82 M   98.60% 0.25%

Castle Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 256 institutional investors and hedge funds held shares of Castle Biosciences Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 2.98 M

RTW INVESTMENTS, LP: 2.76 M

PRINCIPAL FINANCIAL GROUP INC: 1.77 M

Portolan Capital Management, LLC: 1.35 M

DIMENSIONAL FUND ADVISORS LP: 1.04 M

SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC: 940,685

94.13% of Castle Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 32.32 M shares in the last 24 months. This purchase volume represents approximately $873.25 M in transactions.